Download PDF
1 / Pages

Other users also viewed these articles

Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis Carine L. Panke; Cristiane V. Tovo; Cristiane A. Villela-Nogueira; Claudia M. Cravo; Frederico C. Ferreira; Guilherme F.M. Rezende; Fernanda V. Calçado; Ana C.C. Figueiredo-Mendes; Nathalie C. Leite; Gabriela P. Coral; Angelo A. Mattos;
Ann Hepatol. 2020;19:88-91
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29: